Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Leukemia

  Free Subscription


Articles published in Exp Cell Res

Retrieve available abstracts of 13 articles:
HTML format
Text format



Single Articles


    May 2019
  1. WANG MM, Zhuang LK, Zhang YT, Xia D, et al
    A novel specific cleavage of IkappaBalpha protein in acute myeloid leukemia cells involves protease PR3.
    Exp Cell Res. 2019 May 21. pii: S0014-4827(19)30263.
    PubMed     Text format     Abstract available


  2. MORAD SAF, MacDougall MR, Abdelmageed N, Kao LP, et al
    Pivotal role of mitophagy in response of acute myelogenous leukemia to a ceramide-tamoxifen-containing drug regimen.
    Exp Cell Res. 2019 May 18. pii: S0014-4827(19)30262.
    PubMed     Text format     Abstract available


    February 2019
  3. CHEN P, Zhan W, Wang B, You P, et al
    Homoharringtonine potentiates the antileukemic activity of arsenic trioxide against acute myeloid leukemia cells.
    Exp Cell Res. 2019 Feb 11. pii: S0014-4827(19)30056.
    PubMed     Text format     Abstract available


    November 2018
  4. LANG W, Zhu J, Chen F, Cai J, et al
    EVI-1 Modulates Arsenic Trioxide induced Apoptosis through JNK signaling pathway in Leukemia Cells.
    Exp Cell Res. 2018 Nov 22. pii: S0014-4827(18)30852.
    PubMed     Text format     Abstract available


  5. ZHAO H, Li Z, Xie S, Luo Y, et al
    Impairment of Valpha24-Jalpha18(+)Vbeta11(+) natural killer T cells in adult acute lymphoblastic leukemia patients.
    Exp Cell Res. 2018 Nov 12. pii: S0014-4827(18)30855.
    PubMed     Text format     Abstract available


    September 2018
  6. LU X, Zhuang H, Yu Q, Zhang X, et al
    Identification of the UBA2-WTIP fusion gene in acute myeloid leukemia.
    Exp Cell Res. 2018 Sep 1. pii: S0014-4827(18)30541.
    PubMed     Text format     Abstract available


    July 2018
  7. BAMODU OA, Kuo KT, Yuan LP, Cheng WH, et al
    HDAC inhibitor suppresses proliferation and tumorigenicity of drug-resistant chronic myeloid leukemia stem cells through regulation of hsa-miR-196a targeting BCR/ABL1.
    Exp Cell Res. 2018 Jul 12. pii: S0014-4827(18)30440.
    PubMed     Text format     Abstract available


    May 2018
  8. WENJIAN G, Jingrui J, Jiajia P, Rongxing Y, et al
    The change of nuclear LC3 distribution in acute myeloid leukemia cells.
    Exp Cell Res. 2018 May 9. pii: S0014-4827(18)30269.
    PubMed     Text format     Abstract available


  9. HE L, Shi L, Du Z, Huang H, et al
    Mebendazole exhibits potent anti-leukemia activity on acute myeloid leukemia.
    Exp Cell Res. 2018 May 8. pii: S0014-4827(18)30268.
    PubMed     Text format     Abstract available


    February 2018
  10. TIAN WL, Guo R, Wang F, Jiang ZX, et al
    The IRF9-SIRT1-P53 Axis is Involved in the Growth of Human Acute Myeloid Leukemia.
    Exp Cell Res. 2018 Feb 28. pii: S0014-4827(18)30120.
    PubMed     Text format     Abstract available


    December 2017
  11. MIN QH, Wang XZ, Zhang J, Chen QG, et al
    Exosomes derived from imatinib-resistant chronic myeloid leukemia cells mediate a horizontal transfer of drug-resistant trait by delivering miR-365.
    Exp Cell Res. 2017 Dec 6. pii: S0014-4827(17)30643.
    PubMed     Text format     Abstract available


    April 2017
  12. WANG X, Li Y, Chen W, Wang Y, et al
    Nrf-2/Gst-alpha mediated imatinib resistance through rapid 4-HNE clearance.
    Exp Cell Res. 2017;353:72-78.
    PubMed     Text format     Abstract available


    February 2017
  13. SHI XF, Wang H, Kong FX, Xu QQ, et al
    Exosomal miR-486 regulates hypoxia-induced erythroid differentiation of erythroleukemia cells through targeting Sirt1.
    Exp Cell Res. 2017;351:74-81.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: